CFB
UTHR icon

Cullen/Frost Bankers’s United Therapeutics UTHR Stock Holding History

Cullen/Frost Bankers’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.2K Sell
83
-20
-19% -$9.96K ﹤0.01% 802
2025
Q4 		$50.2K Buy
103
+100
+3,333% +$46.6K ﹤0.01% 800
2025
Q3 		$1.26K Hold
3
– – ﹤0.01% 1253
2025
Q2 		$862 Sell
3
-28
-90% -$8.37K ﹤0.01% 1250
2025
Q1 		$9.56K Buy
31
+28
+933% +$9.6K ﹤0.01% 952
2024
Q4 		$1.06K Sell
3
-156
-98% -$57.3K ﹤0.01% 1242
2024
Q3 		$57K Buy
+159
New +$53.7K ﹤0.01% 688
2023
Q1 		– Sell
-489
Closed -$136K – 1261
2022
Q4 		$136K Hold
489
– – ﹤0.01% 554
2022
Q3 		$102K Buy
489
+378
+341% +$84.5K ﹤0.01% 593
2022
Q2 		$26K Buy
+111
New +$22.6K ﹤0.01% 805

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return